Starpharma Holdings LimitedASX: SPL

2026 Annual Report

· Issued by Starpharma Holdings Limited via ASX

Filed with ASX ·

Delivering meaningful patient outcomes with advanced dendrimer technology Annual Report 2026 Contents ABN 20 078 532 180 Highlights 01 Chairman’s Report 02 Chief Executive Officer’s Report 04 Review of Operations 06 Directors’ Report (including Remuneration Report) 12...

View Attachment

6ix hasn’t read this filing yet.

Starpharma Holdings Limited on 6ix

Earlier from Starpharma

Later from Starpharma

All Starpharma news releases